The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.

Novo Nordisk faces a critical phase with its obesity drug Wegovy as it confronts competition from Eli Lilly and potential job ...

Experts reveal potential unintended Ozempic side effect – and whether we should worry - Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent ...